SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors

por Zagouri, Flora, Terpos, Evangelos, Fiste, Oraianthi, Liontos, Michalis, Briasoulis, Alexandros, Katsiana, Ioanna, Skafida, Efi, Markellos, Christos, Kunadis, Elena, Andrikopoulou, Angeliki, Kaparelou, Maria, Koutsoukos, Konstantinos, Gavriatopoulou, Maria, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios-Athanasios
Publicado 2021

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients

por Liontos, Michalis, Terpos, Evangelos, Kunadis, Elena, Zagouri, Flora, Briasoulis, Alexandros, Skafida, Efi, Fiste, Oraianthi, Markellos, Christos, Andrikopoulou, Angeliki, Gumeni, Sentiljana, Kaparelou, Maria, Koutsoukos, Konstantinos, Gavriatopoulou, Maria, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios- Athanasios
Publicado 2021